Celsa, C., Cabibbo, G., Pinato, D.J. (2025). Reply: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment. HEPATOLOGY, 81(3), E103-E104 [10.1097/HEP.0000000000001217].
Reply: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment
Celsa, Ciro;Cabibbo, Giuseppe;
2025-03-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Senza titolo.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
95.17 kB
Formato
Adobe PDF
|
95.17 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
